U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07820228) titled 'Survival Analysis of Early TNBC Women Treated With Dose Dense Sequential Adjuvant Chemotherapy' on Sept. 09.
Brief Summary: Breast cancer remains the most commonly occurring cancer and leading cause of cancer death in women worldwide. According to specific clinical, molecular and genetic characteristics of patients, breast cancer is distinguished into subtypes with differences in disease progression, response to treatment and rate of metastasis. Breast cancer treatment decisions are based mainly on the presence or absence of established prognostic and predictive biomarkers, mainly the estrogen (ER) and progesterone (PR) hormone rec...